Effect of short-term treatment with regular or high doses of omeprazole on the detection of Helicobacter pylori in bleeding peptic ulcer patients

被引:17
作者
Udd, M
Miettinen, P
Palmu, A
Julkunen, R
机构
[1] Univ Helsinki, Cent Hosp, Dept Surg, Helsinki 00029, Finland
[2] Kuopio Univ Hosp, Gastroenterol Unit, Dept Internal Med, SF-70210 Kuopio, Finland
[3] Kuopio Univ Hosp, Dept Surg, SF-70210 Kuopio, Finland
关键词
bleeding; high-dose omeprazole; histology; H. pylori infection; peptic ulcer; regular-dose omeprazole; urease test;
D O I
10.1080/00365520310002193
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: It is unknown whether short-term regular or high-dose omeprazole has any influence on the colonization of Helicobacter pylori in the stomach. We therefore studied the effect of 3-day treatment of 2 different doses of omeprazole. Methods: H. pylori-positive patients with peptic ulcer bleeding (n=101) were randomized to receive either a regular dose (20 mg/day for 3 days)(n=51) or a high dose of omeprazole (80 mg bolus + 8 mg/h infusion/day for 3 days) (n=50). H. pylori status was assessed by histology and urease testing of gastric biopsies pre-entry and after 3-day therapy. Results: With the high dose of omeprazole, tests for the diagnosis of H. pylori became negative significantly more often than with the regular dose (60% versus 27.5%, P=0.001 (any test), 67.6% versus 31.7%, P=0.003 (histology) and 82.2% versus 43.6%, P=0.001 (urease test)). Conclusion: Conversion of the H. pylori tests negative after 3-day treatment of omeprazole is dose-dependent. The diagnosis of H. pylori infection depends on the timing of biopsies in relation to the beginning of proton-pump inhibitor treatment. If samples to find H. pylori are not taken before the treatment, the presence of the bacteria may be overlooked.
引用
收藏
页码:588 / 593
页数:6
相关论文
共 29 条
  • [1] INTRAVENOUS OMEPRAZOLE/AMOXICILLIN AND OMEPRAZOLE PRETREATMENT IN HELICOBACTER PYLORI-POSITIVE ACUTE PEPTIC-ULCER BLEEDING - A PILOT-STUDY
    ADAMEK, RJ
    FREITAG, M
    OPFERKUCH, W
    RUHL, GH
    WEGENER, M
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1994, 29 (10) : 880 - 883
  • [2] Annibale B, 1997, AM J GASTROENTEROL, V92, P790
  • [3] TRIPLE THERAPY ERADICATED HELICOBACTER-PYLORI EQUALLY IN PATIENTS PRETREATED WITH OMEPRAZOLE OR RANITIDINE - A 12-MONTH FOLLOW-UP
    ARCHIMANDRITIS, A
    BALATSOS, V
    DELIS, V
    MENTIS, A
    KASTANAS, K
    SCANDALIS, N
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 1995, 20 (01) : 12 - 16
  • [4] INHIBITION OF HELICOBACTER-PYLORI UREASE BY OMEPRAZOLE
    BUGNOLI, M
    BAYELI, PF
    RAPPUOLI, R
    PENNATINI, C
    FIGURA, N
    CRABTREE, JE
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1993, 5 (09) : 683 - 685
  • [5] EFFECT OF ACID SUPPRESSION ON EFFICACY OF TREATMENT FOR HELICOBACTER-PYLORI INFECTION
    DEBOER, W
    DRIESSEN, W
    JANSZ, A
    TYTGAT, G
    [J]. LANCET, 1995, 345 (8953): : 817 - 820
  • [6] Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers - Randomized double-blind placebo-controlled multicentre study
    DeMuckadell, OBS
    Havelund, T
    Harling, H
    Boesby, S
    Snel, P
    Vreeburg, EM
    Eriksson, S
    Fernstrom, P
    Hasselgren, G
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1997, 32 (04) : 320 - 327
  • [7] FORREST JAH, 1974, LANCET, V2, P394
  • [9] Graham DY, 1997, AM J GASTROENTEROL, V92, P721
  • [10] Griñó P, 2001, SCAND J GASTROENTERO, V36, P1254, DOI 10.1080/003655201317097083